title: Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients.
authors.affiliation: Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
authors.forename: Colleen K
authors.initials: CK
authors.lastname: McIlvennan
authors.affiliation: School of Pharmacy, University of Colorado, Aurora, Colorado.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Page
authors.affiliation: Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
authors.forename: Amrut V
authors.initials: AV
authors.lastname: Ambardekar
authors.affiliation: Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
authors.forename: Andreas
authors.initials: A
authors.lastname: Brieke
authors.affiliation: Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado.
authors.forename: JoAnn
authors.initials: J
authors.lastname: Lindenfeld
mesh_terms: D000328:Adult; D000368:Aged; D000906:Antibodies / Q000097:blood; D000925:Anticoagulants / Q000494:pharmacology / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology*; D005170:Factor X / Q000276:immunology; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D011446:Prospective Studies; D012307:Risk Factors; D013927:Thrombosis / Q000453:epidemiology / Q000517:prevention & control*; D018487:Ventricular Dysfunction, Left / Q000097:blood / Q000628:therapy; D014859:Warfarin / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000906:Antibodies; D000925:Anticoagulants; D014859:Warfarin; D005170:Factor X; D006493:Heparin